---
schema_version: "secwatch.filing_event.v1"
accession: "0001401914-26-000012"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-04-20T23:59:59+00:00"
generated_at: "2026-05-15T05:18:53.535806+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience closes $100K Reg A offering of 20,000 units at $5/unit

## Summary
- Issued 20,000 Investor Units, each: one share Series A Convertible Preferred + two warrants for common stock.
- Gross proceeds of $100,000 from 20,000 units at $5.00 per unit.
- Investor warrants exercisable for up to 40,000 shares of common stock.
- Offering statement qualified by SEC on April 1, 2026; terms previously reported in Jan 29, 2026 8-K.

## SEC filing metadata
- accession: 0001401914-26-000012
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000140191426000012/0001401914-26-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000140191426000012/dare-20260417.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001401914-26-000012
- JSON: https://secwatch.observer/filing/0001401914-26-000012.json
- Plain text: https://secwatch.observer/filing/0001401914-26-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
